Does TRASTUZUMAB DERUXTECAN Cause Lethargy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Lethargy have been filed in association with TRASTUZUMAB DERUXTECAN (Enhertu). This represents 0.3% of all adverse event reports for TRASTUZUMAB DERUXTECAN.
9
Reports of Lethargy with TRASTUZUMAB DERUXTECAN
0.3%
of all TRASTUZUMAB DERUXTECAN reports
2
Deaths
2
Hospitalizations
How Dangerous Is Lethargy From TRASTUZUMAB DERUXTECAN?
Of the 9 reports, 2 (22.2%) resulted in death, 2 (22.2%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Lethargy Listed in the Official Label?
Yes, Lethargy is listed as a known adverse reaction in the official FDA drug label for TRASTUZUMAB DERUXTECAN.
What Other Side Effects Does TRASTUZUMAB DERUXTECAN Cause?
Death (384)
Off label use (258)
Nausea (251)
Myelosuppression (242)
Fatigue (186)
Malignant neoplasm progression (171)
Vomiting (140)
Diarrhoea (132)
Interstitial lung disease (130)
Pneumonitis (125)
What Other Drugs Cause Lethargy?
DULOXETINE (1,682)
ADALIMUMAB (828)
LENALIDOMIDE (585)
METHOTREXATE (563)
GABAPENTIN (496)
AMLODIPINE (466)
TREPROSTINIL (460)
OXYCODONE (452)
MORPHINE (445)
LEVOTHYROXINE (419)
Which TRASTUZUMAB DERUXTECAN Alternatives Have Lower Lethargy Risk?
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DKST
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-DTTB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB EMTANSINE
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-PKRB
TRASTUZUMAB DERUXTECAN vs TRASTUZUMAB-QYYP